Abaxis (ABAX) Declares $0.14 Quarterly Dividend; 1.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend
July 27, 2017 4:01 PM EDTUNION CITY, Calif., July 27, 2017 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the first quarter ended June 30, 2017.
First quarter results include:
Revenues of $58.3 million, up 1% from last year's comparable quarter. Veterinary market revenues of $48.4 million, up 1% over last year's comparable quarter. International revenues of $11.3 million, up 3% over last year's comparable quarter. Revenues from sales of consumables, which include reagent discs, hematology reagent kits,... More